Desupervised vs Iktos

<p>Desupervised is an AI-focused technology platform designed to make advanced analytics accessible to everyday users. It offers bespoke AI solutions tailored to your specific needs, empowering you to leverage state-of-the-art models for better, faster decision-making across many industries. Whether you need predictive insights into commercial activities or custom AI-driven workflows, Desupervised supports your goals.</p> <p>With products like Alviss, their predictive analytics platform, you gain real-time AI insights to drive your business forward. They also specialize in speeding up drug discovery through Bayesian Deep Virtual Screening, highlighting their strength in niche AI applications. Serving multiple markets since 2018 with over 2100 deployed models, Desupervised combines flexibility and expertise, making AI approaches practical and impactful for your operations.</p>

<p>Iktos empowers you to accelerate drug discovery with its innovative AI-driven platform, combining generative molecular design, retrosynthesis planning, and automated lab synthesis. You can follow a molecule's journey from initial design to viable drug candidate, cutting down discovery time to under two years. With features like multi-parametric optimization, customizable synthesis routes, and fully automated workflows, Iktos streamlines complex processes to enhance efficiency in pharmaceutical research.</p> <p>You can leverage Iktos' comprehensive solution that integrates robotics for synthesis, purification, and biological screening using multidimensional data. This suite targets drug developers in pharma, biotech, and academic fields aiming to optimize lead molecules and improve success rates. The platform is backed by robust collaborations and ongoing innovations, making it a reliable partner in bringing new therapeutics to market faster with AI automation.</p>